Diagnostic and therapeutic utility of neuroimaging in depression: an overview

QR Code

Diagnostic and therapeutic utility of neuroimaging in depression: an overview

Toby Wise,1 Anthony J Cleare,1 Andrés Herane,1,2 Allan H Young,1 Danilo Arnone1 1King’s College London, Institute of Psychiatry, Department of Psychological Medicine, Centre for Affective Disorders, London, United Kingdom; 2Clínica Psiquiátrica Universita...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Wise T, Cleare AJ, Herane A, Young AH, Arnone D
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2014
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/29591fb83d2742b395ceb885500dfff2
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Functional neuroimaging of traumatic brain injury: advances and clinical utility
par: Irimia A, et autres
Publié: (2015)

Biomarkers for depression: recent insights, current challenges and future prospects
par: Strawbridge R, et autres
Publié: (2017)

Neuroimaging in eating disorders
par: J&aacute;uregui-Lobera I
Publié: (2011)

A review of neuroimaging studies of anxiety disorders in China
par: Chen J, et autres
Publié: (2011)

MicroRNA as therapeutic targets for treatment of depression
par: Hansen KF, et autres
Publié: (2013)

Uncovering the etiology of conversion disorder: insights from functional neuroimaging [Corrigendum]
par: Ejareh dar M, et autres
Publié: (2016)

Determining a diagnostic cut-off on the Teate Depression Inventory
par: Balsamo M, et autres
Publié: (2014)

Evaluating depressive symptoms in mania: a naturalistic study of patients with bipolar disorder
par: Young AH, et autres
Publié: (2015)

Neuropsychological assessment, neuroimaging, and neuropsychiatric evaluation in pediatric and adult patients with sickle cell disease (SCD)
par: Christopher L Edwards, et autres
Publié: (2007)

Uncovering the etiology of conversion disorder: insights from functional neuroimaging
par: Ejareh dar M, et autres
Publié: (2016)

Recruiting for research studies using online public advertisements examples from research in affective disorders
par: Wise T, et autres
Publié: (2016)

Neuropsychological and neuroimaging markers in prediction of cognitive impairment after ischemic stroke: a prospective follow-up study
par: Mehrabian S, et autres
Publié: (2015)

Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatients
par: Fornaro M, et autres
Publié: (2011)

Cognitive reserve and Aβ1-42 in mild cognitive impairment (Argentina-Alzheimer’s Disease Neuroimaging Initiative)
par: Harris P, et autres
Publié: (2015)

Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use
par: Singh M, et autres
Publié: (2012)

Validity and clinical utilization of the Chinese version of the Gotland Male Depression Scale at a men’s health polyclinic
par: Chu CL, et autres
Publié: (2014)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
par: Robert H Howland
Publié: (2009)

Overview of essential tremor
par: Theresa A Zesiewicz, et autres
Publié: (2010)

Toward an online cognitive and emotional battery to predict treatment remission in depression
par: Gordon E, et autres
Publié: (2015)

Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative
par: Samtani MN, et autres
Publié: (2014)

The Role of ACE2 Receptors of the Olfactory System in Anosmia in COVID-19: An Overview
par: Mohammad Javad Nasr, et autres
Publié: (2021)

Mental health system in Saudi Arabia: an overview
par: Qureshi NA, et autres
Publié: (2013)

Editorial: Machine Learning in Neuroimaging
par: Christian Federau, et autres
Publié: (2021)

Treatment of Lennox-Gastaut syndrome: overview and recent findings
par: Kenou van Rijckevorsel
Publié: (2008)

A review of the potential therapeutic role of statins in the treatment of Alzheimer&rsquo;s disease: current research and opinion
par: Mitchell AJ, et autres
Publié: (2013)

Attitudes and beliefs of patients with chronic depression toward antidepressants and depression
par: Jacob SA, et autres
Publié: (2015)

Consensus recommendation on the use of therapeutic plasma exchange for adult neurological diseases in Southeast Asia from the Southeast Asia therapeutic plasma exchange consortium
par: Fu Liong Hiew, et autres
Publié: (2021)

The importance of norepinephrine in depression
par: Moret C, et autres
Publié: (2011)

The increasing burden of depression
par: L&eacute;pine J-P, et autres
Publié: (2011)

Persistent akathisia masquerading as agitated depression after use of ziprasidone in the treatment of bipolar depression
par: Penders TM, et autres
Publié: (2013)

The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
par: Dannehl K, et autres
Publié: (2014)

Factors associated with antenatal depression in pregnant Korean females: the effect of bipolarity on depressive symptoms
par: Park CM, et autres
Publié: (2014)

Noradrenergic symptom cluster in depression
par: Montgomery S, et autres
Publié: (2011)

Milnacipran: recent findings in depression
par: Guest editors: Stuart Montgomery (London, et autres
Publié: (2010)

Quetiapine monotherapy for bipolar depression
par: Michael E Thase
Publié: (2008)

Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study
par: Anastasia Kuzkina, et autres
Publié: (2021)

A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole
par: Marty Hinz, et autres
Publié: (2010)

Current approaches to treatments for schizophrenia spectrum disorders, part I: an overview and medical treatments
par: Chien WT, et autres
Publié: (2013)

The clinical utility of lurasidone in schizophrenia: patient considerations
par: Harvey PD
Publié: (2015)

Clinical utility of the risperidone formulations in the management of schizophrenia
par: Madaan V, et autres
Publié: (2011)